Edwards Lifesciences Reports Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Edwards Lifesciences (EW) Misses Q4 EPS by 3c, Offers Q1 and FY Guidance
January 27, 2021 4:18 PM ESTEdwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.50, $0.03 worse than the analyst estimate of $0.53. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.19 billion.
GUIDANCE:
Edwards Lifesciences sees Q1 2021 EPS of $0.43-$0.53, versus the consensus of $0.50.... More
